Literature DB >> 23844972

Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation.

Nazem Akoum1, Genaro Fernandez, Brent Wilson, Christopher Mcgann, Eugene Kholmovski, Nassir Marrouche.   

Abstract

INTRODUCTION: Transesophageal echocardiography (TEE) is used to evaluate for left atrial appendage (LAA) thrombi prior to restoration of sinus rhythm in atrial fibrillation (AF). We examined the relationship of atrial fibrosis quantified using late gadolinium enhancement MRI (LGE-MRI) with TEE findings. METHODS AND
RESULTS: We included 178 patients with AF, undergoing TEE and LGE-MRI prior to ablation or cardioversion. LGE-MRI and subsequent image processing was used to quantify atrial fibrosis based on signal intensity analysis. The mean CHADS2 score was 1.24 ± 1.08 and CHA2 DS2 -VASc was 2.08 ± 1.33. The LAA was classified as normal, spontaneous echocardiographic contrast (SEC) present or thrombus present. LAA thrombus was found in 12 patients (6.7%) while SEC was identified in 19 patients (10.7%). Patients with thrombus had higher atrial fibrosis compared to patients without thrombus (26.9 ± 17.4% vs 16.7 ± 10.5%; P < 0.01). Atrial fibrosis was also higher in patients with SEC (23.3 ± 13.7%) compared to those without SEC (16.7 ± 10.8%; P = 0.01). Patients with high atrial fibrosis (>20%) were more likely to have a LAA thrombus (odds ratio 4.6; P = 0.02) and SEC (odds ratio 2.6; P = 0.06). Multivariate logistic regression showed high fibrosis (odds ratio 3.6; P < 0.01) and CHADS2 ≥2 (odds ratio 3.5; P < 0.01) were significant predictors of TEE abnormalities (LAA thrombus or SEC). The area under the curve for the model including high fibrosis, AF type and CHADS2 ≥2 or CHA2 DS2 -VASc ≥2 was 0.73 compared to 0.63 and 0.65 for CHADS2 and CHA2 DS2 -VASc alone.
CONCLUSIONS: Atrial fibrosis is independently associated with appendage thrombus and spontaneous contrast. It provides additional risk stratification not captured by clinical parameters.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  appendage thrombus; atrial fibrillation; catheter ablation; magnetic resonance imaging; stroke; transesophageal echocardiography

Mesh:

Substances:

Year:  2013        PMID: 23844972      PMCID: PMC3818287          DOI: 10.1111/jce.12199

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  13 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

3.  Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus.

Authors:  W Aschenberg; M Schlüter; P Kremer; E Schröder; V Siglow; W Bleifeld
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

4.  Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters.

Authors:  Rui Providência; Ana Botelho; Joana Trigo; Nuno Quintal; José Nascimento; Paula Mota; António Leitão-Marques
Journal:  Europace       Date:  2011-08-24       Impact factor: 5.214

5.  Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation.

Authors:  Marcos Daccarett; Troy J Badger; Nazem Akoum; Nathan S Burgon; Christian Mahnkopf; Gaston Vergara; Eugene Kholmovski; Christopher J McGann; Dennis Parker; Johannes Brachmann; Rob S Macleod; Nassir F Marrouche
Journal:  J Am Coll Cardiol       Date:  2011-02-15       Impact factor: 24.094

6.  Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat.

Authors:  J Ausma; M Wijffels; F Thoné; L Wouters; M Allessie; M Borgers
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

Review 7.  Left atrial appendage: structure, function, and role in thromboembolism.

Authors:  N M Al-Saady; O A Obel; A J Camm
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

8.  Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach.

Authors:  Nazem Akoum; Marcos Daccarett; Chris McGann; Nathan Segerson; Gaston Vergara; Suman Kuppahally; Troy Badger; Nathan Burgon; Thomas Haslam; Eugene Kholmovski; Rob Macleod; Nassir Marrouche
Journal:  J Cardiovasc Electrophysiol       Date:  2010-08-30

9.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

10.  Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation.

Authors:  Daniel Scherr; Kavita Sharma; Darshan Dalal; David Spragg; Karuna Chilukuri; Alan Cheng; Jun Dong; Charles A Henrikson; Saman Nazarian; Ronald D Berger; Hugh Calkins; Joseph E Marine
Journal:  J Cardiovasc Electrophysiol       Date:  2009-12
View more
  46 in total

Review 1.  Assessment and impact of cardiac fibrosis on atrial fibrillation.

Authors:  Nazem Akoum; Nassir Marrouche
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

2.  Association between left atrial low-voltage area, serum apoptosis, and fibrosis biomarkers and incidence of silent cerebral events after catheter ablation of atrial fibrillation.

Authors:  Patrick Müller; Johannes Maier; Johannes-Wolfgang Dietrich; Sebastian Barth; Daniel P Griese; Fabian Schiedat; Attila Szöllösi; Philipp Halbfass; Karin Nentwich; Markus Roos; Joachim Krug; Anja Schade; Rainer Schmitt; Andreas Mügge; Thomas Deneke
Journal:  J Interv Card Electrophysiol       Date:  2015-06-06       Impact factor: 1.900

3.  Impact of low-voltage zones on the left atrial anterior wall on the reduction in the left atrial appendage flow velocity in persistent atrial fibrillation patients.

Authors:  Yuichi Hori; Shiro Nakahara; Naoki Nishiyama; Reiko Fukuda; Tomoaki Ukaji; Hirotsugu Sato; Yuri Koshikawa; Shu Inami; Tetsuya Ishikawa; Sayuki Kobayashi; Yoshihiko Sakai; Isao Taguchi
Journal:  J Interv Card Electrophysiol       Date:  2019-03-18       Impact factor: 1.900

Review 4.  Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.

Authors:  Shadi Yaghi; Hooman Kamel
Journal:  Stroke       Date:  2017-09-15       Impact factor: 7.914

5.  Anticoagulation in patients at high risk of stroke without documented atrial fibrillation. Time for a paradigm shift?

Authors:  Antoni Bayés de Luna; Adrian Baranchuk; Manuel Martínez-Sellés; Pyotr G Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-12-16       Impact factor: 1.468

6.  Cardiac Electrophysiology Under MRI Guidance: an Emerging Technology.

Authors:  Henry Chubb; Steven E Williams; John Whitaker; James L Harrison; Reza Razavi; Mark O'Neill
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

7.  Serum galectin-3 level as a marker of thrombogenicity in atrial fibrillation.

Authors:  Duygu Kocyigit; Kadri Murat Gurses; Muhammed Ulvi Yalcin; Hande Canpinar; Ugur Canpolat; Banu Evranos; Hikmet Yorgun; Necla Ozer; Dicle Guc; Kudret Aytemir
Journal:  J Clin Lab Anal       Date:  2017-03-13       Impact factor: 2.352

Review 8.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.

Authors:  Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah
Journal:  Circulation       Date:  2015-07-28       Impact factor: 29.690

9.  Visualizing radiofrequency lesions using delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation: A modification of the method used by the University of Utah group.

Authors:  Kunihiko Kiuchi; Katsunori Okajima; Akira Shimane; Kiminobu Yokoi; Jin Teranishi; Kousuke Aoki; Misato Chimura; Hideo Tsubata; Taishi Miyata; Yuuki Matsuoka; Takayoshi Toba; Shogo Ohishi; Takahiro Sawada; Yasue Tsukishiro; Tetsuari Onishi; Seiichi Kobayashi; Shinichiro Yamada; Yasuyo Taniguchi; Yoshinori Yasaka; Hiroya Kawai; Kazushi Ikeuchi; Yutaka Shigenaga; Takayuki Ikeda
Journal:  J Arrhythm       Date:  2014-08-07

10.  Visualization of the radiofrequency lesion after pulmonary vein isolation using delayed enhancement magnetic resonance imaging fused with magnetic resonance angiography.

Authors:  Kunihiko Kiuchi; Katsunori Okajima; Akira Shimane; Kiminobu Yokoi; Jin Teranishi; Kousuke Aoki; Misato Chimura; Hideo Tsubata; Taishi Miyata; Yuuki Matsuoka; Takayoshi Toba; Shogo Ohishi; Takahiro Sawada; Yasue Tsukishiro; Tetsuari Onishi; Seiichi Kobayashi; Shinichiro Yamada; Yasuyo Taniguchi; Yoshinori Yasaka; Hiroya Kawai; Kazushi Ikeuchi; Yutaka Shigenaga; Takayuki Ikeda
Journal:  J Arrhythm       Date:  2014-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.